CBX2-depleted samples revealed the downregulation of gene sets mainly related to proliferation, such as E2F and MYC targets, inflammation, and oxidative phosphorylation (Fig. 5B and Supplementary Fig. 2A), which is upregulated in several cancers including leukemia and lymphoma [20, 21]. The gene discussed is CBX2; the disease is leukemia.